Literature DB >> 2184023

Identification of committed mononuclear precursors for osteoclast-like cells formed in long term human marrow cultures.

N Kurihara1, C Chenu, M Miller, C Civin, G D Roodman.   

Abstract

Nonadherent marrow mononuclear cells enriched for hematopoietic progenitor cells were cultured in semisolid medium with recombinant human granulocyte-macrophage colony-stimulating factor for 9 days to form colony forming unit-granulocyte macrophage (CFU-GM) colonies. 1,25-Dihydroxyvitamin D was then gently layered over the cultures. After 2 weeks, approximately 30% of the colonies that formed were composed of cells with a unique polygonal morphology. One hundred percent of the polygonal cells in these colonies crossreacted with the monoclonal antibody 23c6, which preferentially recognizes osteoclasts. Homogenous populations of these polygonal cells formed multinucleated cells (MNC) in suspension culture, 100% of which cross-reacted with the 23c6 monoclonal antibody, and greater than 90% of the MNC contracted in response to calcitonin. Approximately 20% of these MNC formed resorption lacunae on calcified matrices. These results suggest that 1) early osteoclast precursors are derived from CFU-GM, the committed granulocyte-macrophage progenitor; 2) committed mononuclear osteoclast precursors have a distinct polygonal morphology and cross-react with monoclonal antibodies that recognize mature osteoclasts; and 3) these mononuclear precursors are capable of forming multinucleated cells which fulfill the functional criteria for osteoclasts.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2184023     DOI: 10.1210/endo-126-5-2733

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  35 in total

1.  The immune regulatory protein B7-H3 promotes osteoblast differentiation and bone mineralization.

Authors:  W-K Suh; S X Wang; A H Jheon; L Moreno; S K Yoshinaga; B Ganss; J Sodek; M D Grynpas; T W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-18       Impact factor: 11.205

2.  Isolation of a murine osteoclast colony-stimulating factor.

Authors:  M Y Lee; D R Eyre; W R Osborne
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

Review 3.  Historically significant events in the discovery of RANK/RANKL/OPG.

Authors:  T John Martin
Journal:  World J Orthop       Date:  2013-10-18

4.  The role of T cells in osteoporosis, an update.

Authors:  Wen Zhao; Yuying Liu; Catherine M Cahill; Wenlu Yang; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Pathol       Date:  2009-05-20

Review 5.  Osteoimmunology: interactions of the bone and immune system.

Authors:  Joseph Lorenzo; Mark Horowitz; Yongwon Choi
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

6.  Osteoclasts are important for bone angiogenesis.

Authors:  Frank C Cackowski; Judith L Anderson; Kenneth D Patrene; Rushir J Choksi; Steven D Shapiro; Jolene J Windle; Harry C Blair; G David Roodman
Journal:  Blood       Date:  2009-11-03       Impact factor: 22.113

7.  Increased signaling through p62 in the marrow microenvironment increases myeloma cell growth and osteoclast formation.

Authors:  Yuko Hiruma; Tadashi Honjo; Diane F Jelinek; Jolene J Windle; Jaekyoon Shin; G David Roodman; Noriyoshi Kurihara
Journal:  Blood       Date:  2009-03-12       Impact factor: 22.113

8.  Interleukin-11: a new cytokine critical for osteoclast development.

Authors:  G Girasole; G Passeri; R L Jilka; S C Manolagas
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

9.  Giant cell tumor of bone: a neoplasm or a reactive condition?

Authors:  Anwar Ul Haque; Ambreen Moatasim
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

10.  Human blood-mobilized hematopoietic precursors differentiate into osteoclasts in the absence of stromal cells.

Authors:  A Matayoshi; C Brown; J F DiPersio; J Haug; Y Abu-Amer; H Liapis; R Kuestner; R Pacifici
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.